FDA panel against use of Avastin for breast cancer – San Francisco Chronicle

Posted by on Jun 30th, 2011 and filed under Medical News. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry

FDA panel against use of Avastin for breast cancer – San Francisco Chronicle


Los Angeles Times

FDA panel against use of Avastin for breast cancer
San Francisco Chronicle
Stanley Waintraub, chief of breast oncology at New Jersey's John Theurer Cancer Center, testifies in favor of Avastin. A panel of cancer experts ruled Wednesday that Avastin – the world's best-selling cancer drug, developed by Genentech in South San
FDA panel votes against Avastin for breast cancer treatmentWashington Post
One patient's plea for FDA approval of AvastinReuters
FDA advisers vote against Avastin for breast cancer treatmentLos Angeles Times
ABC News –CNN –WebMD
all 920 news articles »

Leave a Reply

    Copyright 2011-2013, www.EHealthJournal.net, Web Site Development & SEO by SecondEffort, Inc.